A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents

Acquired factor V inhibitor represents a rare condition, described only in case reports. The use of activated bypassing agents in bleeding control could be of aid and improve the survival in symptomatic patients with acquired factor V inhibitor.

Detalles Bibliográficos
Autores principales: Giuffrida, Gaetano, Markovic, Uros, Nicolosi, Daniela, Calafiore, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869404/
https://www.ncbi.nlm.nih.gov/pubmed/33598214
http://dx.doi.org/10.1002/ccr3.3586
_version_ 1783648624776839168
author Giuffrida, Gaetano
Markovic, Uros
Nicolosi, Daniela
Calafiore, Valeria
author_facet Giuffrida, Gaetano
Markovic, Uros
Nicolosi, Daniela
Calafiore, Valeria
author_sort Giuffrida, Gaetano
collection PubMed
description Acquired factor V inhibitor represents a rare condition, described only in case reports. The use of activated bypassing agents in bleeding control could be of aid and improve the survival in symptomatic patients with acquired factor V inhibitor.
format Online
Article
Text
id pubmed-7869404
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78694042021-02-16 A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents Giuffrida, Gaetano Markovic, Uros Nicolosi, Daniela Calafiore, Valeria Clin Case Rep Case Reports Acquired factor V inhibitor represents a rare condition, described only in case reports. The use of activated bypassing agents in bleeding control could be of aid and improve the survival in symptomatic patients with acquired factor V inhibitor. John Wiley and Sons Inc. 2020-12-02 /pmc/articles/PMC7869404/ /pubmed/33598214 http://dx.doi.org/10.1002/ccr3.3586 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Giuffrida, Gaetano
Markovic, Uros
Nicolosi, Daniela
Calafiore, Valeria
A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents
title A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents
title_full A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents
title_fullStr A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents
title_full_unstemmed A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents
title_short A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents
title_sort rare case of acquired factor v inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869404/
https://www.ncbi.nlm.nih.gov/pubmed/33598214
http://dx.doi.org/10.1002/ccr3.3586
work_keys_str_mv AT giuffridagaetano ararecaseofacquiredfactorvinhibitorduringtreatmentwithdabigatranforchronicatrialfibrillationsuccessfullytreatedwithbypassingagents
AT markovicuros ararecaseofacquiredfactorvinhibitorduringtreatmentwithdabigatranforchronicatrialfibrillationsuccessfullytreatedwithbypassingagents
AT nicolosidaniela ararecaseofacquiredfactorvinhibitorduringtreatmentwithdabigatranforchronicatrialfibrillationsuccessfullytreatedwithbypassingagents
AT calafiorevaleria ararecaseofacquiredfactorvinhibitorduringtreatmentwithdabigatranforchronicatrialfibrillationsuccessfullytreatedwithbypassingagents
AT giuffridagaetano rarecaseofacquiredfactorvinhibitorduringtreatmentwithdabigatranforchronicatrialfibrillationsuccessfullytreatedwithbypassingagents
AT markovicuros rarecaseofacquiredfactorvinhibitorduringtreatmentwithdabigatranforchronicatrialfibrillationsuccessfullytreatedwithbypassingagents
AT nicolosidaniela rarecaseofacquiredfactorvinhibitorduringtreatmentwithdabigatranforchronicatrialfibrillationsuccessfullytreatedwithbypassingagents
AT calafiorevaleria rarecaseofacquiredfactorvinhibitorduringtreatmentwithdabigatranforchronicatrialfibrillationsuccessfullytreatedwithbypassingagents

Ejemplares similares